0000950170-24-028824.txt : 20240308 0000950170-24-028824.hdr.sgml : 20240308 20240308180001 ACCESSION NUMBER: 0000950170-24-028824 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38978 FILM NUMBER: 24735978 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Tourangeau Greg CENTRAL INDEX KEY: 0001916566 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O FULCRUM THERAPEUTICS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001916566 XXXXXXXX LIVE 0001680581 Fulcrum Therapeutics, Inc. 001-38978 26 Landsdowne St Cambridge MA 02139 617-651-8851 Greg Tourangeau Officer Common Stock Merrill Lynch, Pierce, Fenner & Smith Inc

1400 American Blvd. Pennington NJ 08534

4884 57218.20 61935171 03/08/2024 NASDAQ Common Stock 04/27/2021 Stock option exercises Issuer N 2110 04/27/2021 Cash Common Stock 06/28/2021 Open market purchases Issuer N 2774 06/28/2021 Cash Y 03/08/2024 /s/ Greg Tourangeau